In addition, because of high apoptosis stress induced by persistent DNA damage, p53 deficient ALT cancers are also hypersensitive to suppression of AKT, suggesting that inhibitors of AKT may be especially beneficial in treatment of these ALT cancers (Fig. S5C–E). This evidence concerns the gene AKT1 and cancer.